Agilon Health, Inc. AGL
We take great care to ensure that the data presented and summarized in this overview for agilon health, inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding AGL
View all-
Clayton, Dubilier & Rice, LLC100MShares$231 Million99.35% of portfolio
-
Capital World Investors Los Angeles, CA53.4MShares$123 Million0.04% of portfolio
-
Morgan Stanley New York, NY52MShares$120 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.3MShares$70 Million0.0% of portfolio
-
Black Rock Inc. New York, NY23.2MShares$53.6 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA22.3MShares$51.6 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA15MShares$34.6 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.87MShares$18.2 Million0.01% of portfolio
-
State Street Corp Boston, MA7.4MShares$17.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA6.98MShares$16.1 Million0.0% of portfolio
Latest Institutional Activity in AGL
Top Purchases
Top Sells
About AGL
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Insider Transactions at AGL
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 28
2025
|
Jeffrey A. Schwaneke Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,331
-0.83%
|
$18,662
$2.35 P/Share
|
May 28
2025
|
Diana Mckenzie Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,724
+36.4%
|
-
|
May 28
2025
|
John William Wulf Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,724
+21.65%
|
-
|
May 28
2025
|
Karen Mc Loughlin Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,724
+34.14%
|
-
|
May 28
2025
|
Ronald A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,724
+2.1%
|
-
|
May 28
2025
|
Silvana Battaglia Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,724
+35.21%
|
-
|
May 28
2025
|
Sharad Mansukani Director |
BUY
Grant, award, or other acquisition
|
Direct |
78,724
+5.5%
|
-
|
May 24
2025
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
193
-0.17%
|
$386
$2.22 P/Share
|
Apr 15
2025
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,641
-1.66%
|
$73,205
$5.53 P/Share
|
Apr 15
2025
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
22,563
-2.55%
|
$112,815
$5.53 P/Share
|
Apr 15
2025
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,226
-2.99%
|
$41,130
$5.53 P/Share
|
Apr 15
2025
|
Denise Zamore Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,490
-1.22%
|
$27,450
$5.53 P/Share
|
Apr 15
2025
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,022
-2.55%
|
$15,110
$5.53 P/Share
|
Apr 14
2025
|
Benjamin Shaker Chief Markets Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,665
-0.41%
|
$18,325
$5.6 P/Share
|
Apr 14
2025
|
Steven Sell CEO & President |
SELL
Payment of exercise price or tax liability
|
Direct |
7,898
-0.88%
|
$39,490
$5.6 P/Share
|
Apr 14
2025
|
Girish Venkatachaliah Chief Technology Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,808
-1.01%
|
$14,040
$5.6 P/Share
|
Apr 14
2025
|
Denise Zamore Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
517
-0.11%
|
$2,585
$5.6 P/Share
|
Apr 14
2025
|
Timothy Gertsch Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.56%
|
$3,310
$5.6 P/Share
|
Apr 01
2025
|
Steven Sell CEO & President |
BUY
Grant, award, or other acquisition
|
Direct |
551,471
+37.82%
|
-
|
Apr 01
2025
|
Timothy Gertsch Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
61,275
+33.98%
|
-
|
Last 12 Months Summary
Grant, award, or other acquisition | 2.54M shares |
---|---|
Open market or private purchase | 199K shares |
Payment of exercise price or tax liability | 102K shares |
---|